Question Number: 199
PDR Number: SQ22-000124
Date Submitted: 24/02/2022
Department or Body: Department of Health
70. The remit of Australian Technical Advisory Group on Immunisation (ATAGI) does not extend to requesting the Therapeutic Goods Administration (TGA) to disclose details relating to adverse events. To protect patient confidentiality, the TGA does not disclose individual adverse event following immunisation reports that have been submitted. Individual reports contain identifying information about individuals and sensitive information about their health. De-identified adverse event reports received by the TGA are published in the Database of Adverse Event Notification on the TGA website 14 days after they are included in the TGA’s internal database.
71. The Australian Health Protection Principal Committee, ATAGI and the TGA will continue to constantly monitor the COVID-19 pandemic and the emerging evidence on vaccines – both domestically and internationally – and will continue to provide expert, independent advice to the Government.
72. ATAGI is not reliant on reports of passive surveillance of vaccinated children in the USA. ATAGI considers all available information, including clinical trials data, published research and reports from other international regulators, as well as real world experience of the particular vaccine in other population groups, in providing its advice to the Minister for Health.